Headlines
- Celgene, Gilead, and Biogen could go much higher, says Bernsteinat theflyonthewall.com(Fri 7:20AM EDT)
- Final Glance: Biotechnology companiesAP(Thu May 23)
- A Trio of ETFs Sitting on 30% Gains This YearETF Trends(Thu May 23)
- Amgen Stock Checkup for Mayat Motley Fool(Thu May 23)
- Midday Glance: Biotechnology companiesAP(Thu May 23)
- Cirrus Logic Tumbles On Profit Margin Guidance and 2 Other Hot Stocks to Watchat Wall St. Cheat Sheet(Thu May 23)
- Early Glance: Biotechnology companiesAP(Thu May 23)
- Gilead's Sofosbuvir under European ReviewZacks(Wed May 22)
- Watch This HCV Playerat Motley Fool(Wed May 22)
- Buy Bristol-Myers, Says Citi; Stock Jumps 7%at Barrons.com(Wed May 22)
- [video] Best Buy: Buy, Sell or Hold?at CNBC(Wed May 22)
- Hedge Funds Trail S&P 500 by 10 Percentage Points, Goldman Saysat Bloomberg(Wed May 22)
- Tiger Cub John Griffin's Top Stock Picks For Q2at Seeking Alpha(Wed May 22)
- Gilead Stock Hits New 52-Week High (GILD)at TheStreet(Wed May 22)
- [$$] A Sampling of "High-Conviction" Stocks and Other Namesat Barrons.com(Tue May 21)
Press Releases
- StockCall Study on Gilead Sciences, NPS Pharma, InterMune, Seattle Genetics, and Halozyme TherapeuticsAccesswire(Wed Apr 24)
- Data from Phase 3 studies of Gilead's sofosbuvir for hepatitis C to be presented at 48th Annual EASL Meeting; Findings published online today in The New England Journal of MedicineCNW Group(Tue Apr 23)
- Active Buzzers: Citigroup Inc, Boston Scientific Corporation, Morgan Stanley, Gilead SciencesAccesswire(Mon Apr 22)
Must Read
- U.S. markets headed lower amid durable goods data, long weekendThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Cyprus eliminates money withdrawal, transfer limits for another 2 foreign banksThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Manitoba Tel to sell Allstream to Accelero, put $130 million into pensionThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TSX may open lower on fears of less Fed stimulusReuters(1969-12-31T18:59:59GMT-05:00)
- Restructured Heroux-Devtek shows reduced Q4 profit, revenue from core operationsThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
